By Morgan Stanley’s Mike Wilson and Team With bond markets questioning the Fed’s dot plot, bond volatility has increased markedly. We think stocks are next as investors realize earnings guidance looks unrealistic. This is when the ERP typically reprices, and stocks may finally get ahead of the downside we see in earnings estimates. Bond markets no longer appear to believe…
Morgan Stanley’s Weekly Warm-up: When Markets Question the “Higher Powers,” They Can Re-price Quickly
A financial market resource for the every-day investor and trader.
-
My Plans For Success In 2017 Continue To Involve VIX-Leveraged ETFs/ETNs
Seth Golden, , Research Reports, 0
In 2016, the Golden Capital Portfolio managed to achieve a 167% return on capital invested. Capital allocation was largely...
-
Weekly Warm-up: Winter Is Coming but Arrival Is Unclear
Seth Golden, , Research Reports, 0
With the Fire portion of our Fire and Ice thesis playing out, we await the timing and magnitude of...
-
Leuthold Group: An INEXPLICABLE Stock Market
Seth Golden, , Research Reports, 0
Since at least Jackson Hole, the narrative has been that inflation is a big problem, and the Federal Reserve...
-
Investing: Make “Time” Your Best Friend
Seth Golden, , Research Reports, 0
Welcome back! Every week, Seth and I discuss all the facets of the market and what are the factors...
-
UVXY: Market Uncertainty And Telling The Untold Future
Seth Golden, , Research Reports, 0
In my office I have framed the famous quote, “Know from whence you came. If you know whence you...
-
Weekly State of the Market: Some Great TIPS
Seth Golden, , Research Reports, 0
“I don’t think you can get to be a really good investor over a broad range without doing a...
-
J.P. Morgan: Add to risk as a lot of negativity is already priced in
Seth Golden, , Research Reports, 0
Cross-Asset Strategy: As geopolitical risks intensified over the past month, our OWs in Commodities and Energy stocks outperformed, while...
-
Morgan Stanley Biotechnology Team: Year-End Vaccine Probable
Seth Golden, , Research Reports, 0
Biotechnology | North America COVID-19: Increasing ConvictionMultiple Vaccine Candidates WillHave Pivotal Data Before YE20 While a pre-election result is...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00